{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:04:53Z","timestamp":1788228293560,"version":"build-2803163510"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dent Res"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijdr.ijdr_379_16","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T03:30:16Z","timestamp":1500003016000},"page":"261","source":"Crossref","is-referenced-by-count":24,"title":["Oral changes in patients undergoing chemotherapy for breast cancer"],"prefix":"10.4103","volume":"28","author":[{"given":"Shruthi","family":"Acharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KeerthilathaMurlidhar","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ballal","family":"Mamatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VadhirajM","family":"Bejadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashidhar","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0970-9290.210677-1","first-page":"33","volume-title":"Global cancer statistics","author":"Parkin","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"key-10.4103\/0970-9290.210677-2","unstructured":"Indian Council of Medical Research. National Cancer Registry Program: A Ten year Consolidated Report of the Hospital Based Cancer Registries, 1984-1993. An Assessment of the Burden and Care of Cancer Patients. New Delhi: ICMR; 2001."},{"key":"key-10.4103\/0970-9290.210677-3","first-page":"1031","volume-title":"Spectrum of breast cancer in Asian women","author":"Agarwal","year":"2007","journal-title":"World J Surg"},{"key":"key-10.4103\/0970-9290.210677-4","first-page":"1","volume-title":"Anthracyclines in the treatment of cancer.An overview","author":"Hortob\u00e1gyi","year":"1997","journal-title":"Drugs"},{"key":"key-10.4103\/0970-9290.210677-5","first-page":"611","volume-title":"Metabolism and transport of oxazaphosphorines and the clinical implications","author":"Zhang","year":"2005","journal-title":"Drug Metab Rev"},{"key":"key-10.4103\/0970-9290.210677-6","first-page":"1995","volume-title":"Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients","author":"Sonis","year":"2004","journal-title":"Cancer"},{"key":"key-10.4103\/0970-9290.210677-7","first-page":"207","volume-title":"Xerostomia and hypofunction of the salivary glands in cancer therapy","author":"Jensen","year":"2003","journal-title":"Support Care Cancer"},{"key":"key-10.4103\/0970-9290.210677-8","first-page":"93","volume-title":"Oral microflora in patients with salivary gland hypofunction","author":"Hofer","year":"2004","journal-title":"Oral Biosci Med"},{"key":"key-10.4103\/0970-9290.210677-9","first-page":"348","volume-title":"Neoadjuvant chemotherapy in operable breast cancer: The pros","author":"Mamounas","year":"2006","journal-title":"Breast Care"},{"key":"key-10.4103\/0970-9290.210677-10","doi-asserted-by":"crossref","unstructured":"Martin M, Villar A, Sole-Calvo A, Gonzalez R, Massuti B, Lizon J, et al. Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group. Ann Oncol 2003;14:833-42.","DOI":"10.1093\/annonc\/mdg260"},{"key":"key-10.4103\/0970-9290.210677-11","first-page":"322","volume-title":"Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy","author":"Peterson","year":"2007","journal-title":"Cancer"},{"key":"key-10.4103\/0970-9290.210677-12","first-page":"3374","volume-title":"Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-25","author":"Fisher","year":"1999","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0970-9290.210677-13","first-page":"825","volume-title":"High dose, dose-intensive chemotherapy with doxorubicin and cyclophosphamide for the treatment of advanced breast cancer","author":"Ferguson","year":"1993","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0970-9290.210677-14","first-page":"3637","volume-title":"Dose-dense anthracycline-based chemotherapy for node-positive breast cancer","author":"Ellis","year":"2002","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0970-9290.210677-15","first-page":"413","volume-title":"Patterns of sore mouth in outpatients with cancer receiving chemotherapy","author":"Brown","year":"2009","journal-title":"Support Care Cancer"},{"key":"key-10.4103\/0970-9290.210677-16","first-page":"697","volume-title":"Taste changes experienced by patients receiving chemotherapy","author":"Wickham","year":"1999","journal-title":"Oncol Nurs Forum"},{"key":"key-10.4103\/0970-9290.210677-17","first-page":"581","volume-title":"Subjective reports of xerostomia and objective measures of salivary gland performance","author":"Fox","year":"1987","journal-title":"J Am Dent Assoc"},{"key":"key-10.4103\/0970-9290.210677-18","unstructured":"Leopold DA, Holbrook EH. Disorders of Taste and Smell. Available from: http:\/\/www.emedicine.com\/ent\/topic333.htm. [Last accessed on 2008 Oct 17]."},{"key":"key-10.4103\/0970-9290.210677-19","unstructured":"World Health Organization. Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization; 1979. p. 15-22."},{"key":"key-10.4103\/0970-9290.210677-20","first-page":"111","volume-title":"A proposal for reclassification of oral candidosis","author":"Ax\u00e9ll","year":"1997","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"key-10.4103\/0970-9290.210677-21","unstructured":"Segal E, Elad D. Candidiasis. In: Merz WG, Hay RJ, editors. Topley and Wilson's Microbiology and Microbial Infections: Medical Mycology. London: Hodder Arnold; 2005. p. 579-623."},{"key":"key-10.4103\/0970-9290.210677-22","unstructured":"Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. Manual of Clinical Microbiology. Washington: ASM Press; 2003. p. 694."},{"key":"key-10.4103\/0970-9290.210677-23","first-page":"1158","volume-title":"A comparison of whole mouth resting and stimulated salivary measurement procedures","author":"Navazesh","year":"1982","journal-title":"J Dent Res"},{"key":"key-10.4103\/0970-9290.210677-24","first-page":"291","volume-title":"Saliva: Its role in health and disease","author":"Sreebny","year":"1992","journal-title":"Int Dent J"},{"key":"key-10.4103\/0970-9290.210677-25","first-page":"85","volume-title":"Interpretation and use of microbiologic findings in dental caries","author":"Krasse","year":"1986","journal-title":"Oral Microbiol Immunol"},{"key":"key-10.4103\/0970-9290.210677-26","first-page":"45","volume-title":"A clinical evaluation of the ability of the Dentobuff method to estimate buffer capacity of saliva","author":"Wikner","year":"1985","journal-title":"Swed Dent J"},{"key":"key-10.4103\/0970-9290.210677-27","first-page":"22","volume-title":"Clinical aspects of salivary biology for the dental clinician","author":"Walsh","year":"2007","journal-title":"Int Dent S Afr"},{"key":"key-10.4103\/0970-9290.210677-28","first-page":"355","volume-title":"Sabouraud('s) agar","author":"Odds","year":"1991","journal-title":"J Med Vet Mycol"},{"key":"key-10.4103\/0970-9290.210677-29","first-page":"3","volume-title":"Oral microbiology: Isolation and identification of Candida from the oral cavity","author":"Williams","year":"2000","journal-title":"Oral Dis"},{"key":"key-10.4103\/0970-9290.210677-30","first-page":"10","volume-title":"Evaluation of clinical efficacy of fluconazole mouth rinse for treatment of oral candidiasis","author":"Ramesh","year":"2010","journal-title":"Ann Essences Dent"},{"key":"key-10.4103\/0970-9290.210677-31","unstructured":"National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Screening and Diagnosis V.I.2010. 2008. http:\/\/www.nccn.org\/professionals\/ physician_gls\/PDF\/breast-screening.pdf. [Last accessed on 2009 Nov 17]."},{"key":"key-10.4103\/0970-9290.210677-32","first-page":"1724","volume-title":"Dose-dense adjuvant chemotherapy in early breast cancer patients: Results from a randomized trial","author":"Venturini","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0970-9290.210677-33","first-page":"805","volume-title":"Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer","author":"Mart\u00edn","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0970-9290.210677-34","first-page":"2195","volume-title":"Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy","author":"Rivera","year":"2000","journal-title":"Cancer"},{"key":"key-10.4103\/0970-9290.210677-35","first-page":"2169","volume-title":"Doxorubicin and paclitaxel in advanced breast carcinoma: Importance of prior adjuvant anthracycline therapy","author":"Lluch","year":"2000","journal-title":"Cancer"},{"key":"key-10.4103\/0970-9290.210677-36","first-page":"91","volume-title":"Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions","author":"Barasch","year":"2003","journal-title":"Oral Oncol"},{"key":"key-10.4103\/0970-9290.210677-37","first-page":"680","volume-title":"Oral complications of cancer therapy","author":"Sonis","year":"2002","journal-title":"Oncology (Williston Park)"},{"key":"key-10.4103\/0970-9290.210677-38","doi-asserted-by":"crossref","unstructured":"Toth BB, Martin JW, Fleming TJ. Oral complications associated with cancer therapy. An M. D. Anderson Cancer Center experience. J Clin Periodontol 1990;17:508-15.","DOI":"10.1111\/j.1365-2710.1992.tb01225.x"},{"key":"key-10.4103\/0970-9290.210677-39","first-page":"E17","volume-title":"Clinical evaluation of dental and periodontal status in a group of oncological patients before chemotherapy","author":"L\u00f3pez-Galindo","year":"2006","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"key-10.4103\/0970-9290.210677-40","first-page":"1007","volume-title":"A systematic review of dental disease in patients undergoing cancer therapy","author":"Hong","year":"2010","journal-title":"Support Care Cancer"},{"key":"key-10.4103\/0970-9290.210677-41","first-page":"36","volume-title":"Mouth care for nasopharyngeal cancer patients undergoing radiotherapy","author":"Shieh","year":"1997","journal-title":"Oral Oncol"},{"key":"key-10.4103\/0970-9290.210677-42","first-page":"1615","volume-title":"Pigmentation of the tongue and mucous membranes associated with cancer chemotherapy","author":"Krutchik","year":"1979","journal-title":"South Med J"},{"key":"key-10.4103\/0970-9290.210677-43","first-page":"433","volume-title":"Determination of epirubicin and its metabolite epirubicinol in saliva and plasma by HPLC","author":"Dodde","year":"2003","journal-title":"Ther Drug Monit"},{"key":"key-10.4103\/0970-9290.210677-44","first-page":"274","volume-title":"Therapy-induced dysfunction of salivary glands: Implications for oral health","author":"Baum","year":"1985","journal-title":"Spec Care Dentist"},{"key":"key-10.4103\/0970-9290.210677-45","first-page":"623","volume-title":"The functions of saliva","author":"Mandel","year":"1987","journal-title":"J Dent Res"},{"key":"key-10.4103\/0970-9290.210677-46","first-page":"838","volume-title":"Interaction of saliva and taste","author":"Spielman","year":"1990","journal-title":"J Dent Res"},{"key":"key-10.4103\/0970-9290.210677-47","first-page":"217","volume-title":"Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients","author":"Jensen","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"key-10.4103\/0970-9290.210677-48","first-page":"96","volume-title":"The establishment of a xerostomia clinic: A prospective study","author":"Field","year":"1997","journal-title":"Br J Oral Maxillofac Surg"},{"key":"key-10.4103\/0970-9290.210677-49","first-page":"145","volume-title":"Perceived taste disturbance in adults: Prevalence and association with oral and psychological factors and medication","author":"Bergdahl","year":"2002","journal-title":"Clin Oral Investig"},{"key":"key-10.4103\/0970-9290.210677-50","first-page":"484","volume-title":"Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil","author":"McCarthy","year":"1998","journal-title":"Oral Oncol"},{"key":"key-10.4103\/0970-9290.210677-51","first-page":"545","volume-title":"The effect of cytotoxic therapy on saliva and oral flora","author":"Main","year":"1984","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"key-10.4103\/0970-9290.210677-52","first-page":"109","volume-title":"Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: An exploratory study","author":"Harrison","year":"1998","journal-title":"Spec Care Dentist"},{"key":"key-10.4103\/0970-9290.210677-53","first-page":"162","volume-title":"Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction","author":"Jensen","year":"2008","journal-title":"Oral Oncol"},{"key":"key-10.4103\/0970-9290.210677-54","first-page":"411","volume-title":"Changes in the oral microflora in patients with acute leukemia and related disorders during the period of induction therapy","author":"Wahlin","year":"1988","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"key-10.4103\/0970-9290.210677-55","unstructured":"Eisenberg HD. Essential Procedure for Clinical Microbiology. Washington, DC: ASM Press Publication; 1998. p. 286."},{"key":"key-10.4103\/0970-9290.210677-56","first-page":"265","volume-title":"Dental management of head and neck cancer patients","author":"Carl","year":"1980","journal-title":"J Surg Oncol"},{"key":"key-10.4103\/0970-9290.210677-57","first-page":"58","volume-title":"Taste and odor abnormalities in cancer patients","author":"Hong","year":"2009","journal-title":"J Support Oncol"}],"container-title":["Indian Journal of Dental Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:33:48Z","timestamp":1786714428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijdr.IJDR_379_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"alternative-id":["210677"],"URL":"https:\/\/doi.org\/10.4103\/ijdr.ijdr_379_16","relation":{},"ISSN":["0970-9290"],"issn-type":[{"value":"0970-9290","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}